Haley Guiliano and Karen Mangasarian Shortlisted for 2024 Managing IP Awards
Haley Guiliano (HG), capping off a banner year of recognition and awards, has been invited to the 2024 Managing IP Awards for the Americas Region and nominated for two awards.
Regarded as one of the most respected awards in the IP, the annual Managing IP Awards shortlist follows months of thorough research involving peer review, market evaluation, and client references.
Unveiled on February 22, 2024, HG received two first-time nominations:
Firm- Boutique Firm of the Year Award
Partner Karen Mangasarian– Practitioner of the Year for Patent Prosecution
Co-founding Partner and Head of Life Sciences at HG James F. Haley, Jr. remarked, “I am delighted to see HG shortlisted this year as a firm. This is a welcome validation of our team’s efforts and a testament to our range within the IP specialty. I am especially proud of Karen’s individual recognition; she brings tremendous value to our clients and firm.”
We send our warmest congratulations and best wishes to our fellow nominees; and look forward to seeing them at The Managing IP Awards Ceremony, which will take place on April 25, 2024, at the JW Marriott Essex House in New York City.
About Karen Mangasarian:
Karen Mangasarian specializes in advising biotechnology, pharmaceutical, and life sciences clients on worldwide patent portfolio management, patent life cycle strategies, and competitive patent strategies. She offers expertise in patent landscapes, invalidity, patentability, non-infringement, and freedom-to-operate analyses, along with conducting IP due diligence investigations and guiding clients through transactions such as license agreements, joint ventures, collaborations, and mergers and acquisitions. With a diverse focus on life sciences technology, Karen has successfully collaborated across areas including small molecule pharmaceuticals, antibody therapies, gene therapy, CRISPR, and diagnostic and therapeutic methods in molecular and cellular biology, immunology, microbiology, biochemistry, genomics, and computational biology. Moreover, she brings extensive experience in managing contentious patent matters, encompassing interferences, re¬examinations, oppositions, and litigation.
